低出生体重の小児の健康と発達状態について,学齢期の小児の健康と発達状態について
M C McCormick1, J Brooks-Gunn, K Workman-Daniels
1Department of Maternal and Child Health, Harvard School of Public Health, Boston, Mass 02115.
JAMA
|April 22, 1992
まとめ
低出生体重で生まれた子供は,学校時代により多くの健康問題に直面します. 早期の介入プログラムは,早産児の成果を改善し,長期的な健康問題を軽減するために不可欠です.
科学分野:
- 小児科は小児科です.
- ネオナタロジーの新生児科
- 発達小児科 発達小児科
背景:
- 胎児の生存率を向上させるためには,胎児の長期的な健康状態の理解が必要である.
- 学齢期の成果を評価することで,早産と低出生体重の影響について重要な洞察が得られます.
研究 の 目的:
- 異なる出生体重で生まれた子供の学校年齢の健康状態を評価し,早産児の生存率の増加の影響に焦点を当てます.
- 異なる出生体重カテゴリーに関連した特定の健康疾患と発達上のアウトカムを特定する.
主な方法:
- 初期コホート研究の設計.
- 低出生体重 (<=1500g) の乳児と,重出生体重の乳児の層格化されたランダムサンプルの含有.
- 適格な参加者の65.1%に対して,インタビューと自宅/診療所訪問を使用して,8~10年のフォローアップを行った.
主要な成果:
- 出生体重の減少は,感情的健康を除くほとんどの指標で,罹病率の増加と相関していました.
- 出生体重 <=1500gの乳児は,複数の健康問題を経験する確率が高かった.
- 母親の教育は,1000g以上の子供のIQ結果に影響を与え,社会経済的不利益は出生体重に関係なくすべての子供に悪影響を及ぼしました.
結論:
- 低出生体重は,学年初期における罹病率の増加と関連しています.
- 退院後および早期介入プログラムは,リスクを軽減し,脆弱な子どもの長期的な健康を改善するために不可欠です.
- これらの長期的な結果を理解することは,低出生体重で生まれた子供の継続的なサポートとモニタリングの必要性を強調します.
関連する概念動画
01:10Nature and Nurture
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...